tm
Seeing Is Believing
tm
Seeing Is Believing
IPHA is currently covered by 2 analysts with an average price target of $5.94. This is a potential upside of $3.97 (201.52%) from yesterday's end of day stock price of $1.97.
Innate Pharma's activity chart (see below) currently has 22 price targets and 26 ratings on display. The stock rating distribution of IPHA is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 46 days.
Highest price target for IPHA is $5, Lowest price target is $2, average price target is $3.5.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 29-Oct-2025. First documented stock forecast 14-Dec-2020.
Currently out of the existing stock ratings of IPHA, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$5
$3.03 (153.81%)
5 days ago
(29-Oct-2025)
0/9 (0%)
$2.93 (141.55%)
Hold
$2
$0.03 (1.52%)
$9
1 months 16 days ago
(18-Sep-2025)
2/6 (33.33%)
$0.06 (3.09%)
138
Buy
$12
$10.03 (509.14%)
$14
3 years 1 months 18 days ago
(16-Sep-2022)
0/2 (0%)
$8.93 (290.88%)
What is IPHA (Innate Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on IPHA (Innate Pharma) with a proven track record?
Which analyst has the current lower performing score on IPHA (Innate Pharma) with a proven track record?
Which analyst has the most public recommendations on IPHA (Innate Pharma)?
Which analyst is the currently most bullish on IPHA (Innate Pharma)?
Which analyst is the currently most reserved on IPHA (Innate Pharma)?
